Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Non-ST-Elevation Coronary Syndromes and Multivessel Disease: A Systematic Review and Meta-Analysis.

[1]  Yong Hwan Park,et al.  Intravascular Imaging-Guided or Angiography-Guided Complex PCI. , 2023, The New England journal of medicine.

[2]  N. Al-Attar,et al.  Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. , 2021, The New England journal of medicine.

[3]  P. Serruys,et al.  Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study , 2021, European heart journal.

[4]  Jun-Jie Zhang,et al.  3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. , 2020, JACC. Cardiovascular interventions.

[5]  Heather B. Blunt,et al.  PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews , 2021, Systematic Reviews.

[6]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[7]  M. Flather,et al.  Effect of total arterial grafting in the Arterial Revascularization Trial. , 2020, The Journal of thoracic and cardiovascular surgery.

[8]  G. Mintz,et al.  Effect of Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial. , 2020, JACC. Cardiovascular interventions.

[9]  P. Kolh,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial , 2019, The Lancet.

[10]  P. Gonçalves,et al.  Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary Disease. , 2019, The American journal of cardiology.

[11]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[12]  P. Gąsior,et al.  Long-term outcomes of patients with multivessel coronary artery disease presenting non-ST-segment elevation acute coronary syndromes , 2013, Cardiology journal.

[13]  G. Torregrossa,et al.  New Strategies for Surgical Myocardial Revascularization , 2018, Circulation.

[14]  Wichor M Bramer,et al.  A systematic approach to searching: an efficient and complete method to develop literature searches , 2018, Journal of the Medical Library Association : JMLA.

[15]  R. Rodríguez-Olivares,et al.  Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease. , 2018, Cardiovascular revascularization medicine : including molecular interventions.

[16]  V. Fuster,et al.  Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.

[17]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[18]  P. Serruys,et al.  Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome. , 2017, The American journal of cardiology.

[19]  T. Maddox,et al.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, Ameri , 2017, Journal of the American College of Cardiology.

[20]  Habib Samady,et al.  Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial , 2016, The Lancet.

[21]  E. Ohman,et al.  Surgical Versus Percutaneous Coronary Revascularization for Multivessel Disease in Diabetic Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome: Analysis From the Acute Catheterization and Early Intervention Triage Strategy Trial , 2015, Circulation. Cardiovascular interventions.

[22]  P. V. von Hippel,et al.  The heterogeneity statistic I2 can be biased in small meta-analyses , 2015, BMC Medical Research Methodology.

[23]  A. Yeung,et al.  Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[24]  M. Mack,et al.  Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score , 2013, Circulation.

[25]  Michail I. Papafaklis,et al.  The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. , 2013, Journal of the American College of Cardiology.

[26]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[27]  B. Gersh,et al.  Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.

[28]  G. Stone,et al.  Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2010, JACC. Cardiovascular interventions.

[29]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[30]  G. Sangiorgi,et al.  A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.

[31]  S. Pocock,et al.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[32]  Samin K. Sharma,et al.  Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. , 2009, JACC. Cardiovascular interventions.

[33]  P. Serruys,et al.  Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials , 2008, Circulation.

[34]  Reza Ardehali,et al.  Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery , 2007, Annals of Internal Medicine.

[35]  Simon Wandel,et al.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.

[36]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[37]  Samin K. Sharma,et al.  Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[38]  E. Boersma,et al.  Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. , 2006, European heart journal.

[39]  J. Boura,et al.  Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials , 2006, The Lancet.

[40]  J. Spertus,et al.  The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial. , 2005, American heart journal.

[41]  M. Bonardi,et al.  Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study , 2004, International journal of cardiovascular interventions.

[42]  W. O’Neill,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2000, The New England journal of medicine.

[43]  K. Lee,et al.  Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.